Wall Street Analysts See a 211.07% Upside in iTeos Therapeutics (ITOS): Can the Stock Really Move This High?

Shares of iTeos Therapeutics, Inc. (ITOS) have gained 31.6% over the past four weeks to close the last trading session at $7.50, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$23.33 indicates a potential upside of 211.1%.The average comprises six short-term price targets ranging from a low of $15 to a high of$47, with a standard deviation of $12.21. While the lowest estimate ...